Why the study?
Does pharmacologic treatment reduce cardiovascular morbidity and mortality in adults with mild essential hypertension?
Does pharmacologic treatment reduce cardiovascular morbidity and mortality in adults with mild essential hypertension?
This review highlights the balance between the cardiovascular benefits of pharmacologic treatment for mild hypertension and the associated costs and side effects.
No takes yet. Share an insight, caveat, or question.
Balance benefits against costs and side effects before treating mild hypertension; leaves open optimal initiation thresholds.
Richard I. Kopelman (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: